Metabolic dysfunction-associated fatty liver disease (MAFLD) is a chronic condition
characterized by hepatic fat accumulation combined with underlying metabolic …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide, with a global prevalence of approximately 30%. However, the prevalence of …

Evidence suggests a close connection between Nonalcoholic Fatty Liver Disease (NAFLD)
and increased cardiovascular (CV) risk. Several cross-sectional studies report that NAFLD is …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, with
an estimated prevalence of 25% globally. NAFLD is closely associated with metabolic …

Introduction Inflammation is a common unifying factor in experimental models of non-
alcoholic fatty liver disease (NAFLD) progression. Recent evidence suggests that housing …

Nonalcoholic fatty liver disease (NAFLD), the most prominent cause of chronic liver disease
worldwide, is a rapidly growing epidemic. It consists of a wide range of liver diseases, from …

The obesity epidemic is one of the major health concerns of the 21st century. Nonalcoholic
fatty liver disease (NAFLD) is linked with the increased adiposity associated with obesity …

Development and severity of nonalcoholic fatty liver disease (NAFLD) have been linked to
obesity and white adipose tissue (WAT) dysfunction plays a key role in this relation. We …

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome (MetS), and type 2 diabetes
(T2DM) are metabolic disorders that belong to a highly prevalent disease cluster with a …

Senescence is considered to be a cardinal player in several chronic inflammatory and
metabolic pathologies. The two dominant mechanisms of senescence include replicative …